Daniel123 · Newsroom
Pericarditis Global Clinical Trials Review, H2, 2016 - Market Trends, Regulations, and Competitive Landscape examined in new market
GlobalData's clinical trial report, “Pericarditis Global Clinical Trials Review, H2, 2016" provides an overview of Pericarditis clinical trials scenario.September 9, 2016
Global Unstable Angina Clinical Trials Review, H2, 2016 - Investment Trends, Regulations and Company Profiles examined in new market
GlobalData's clinical trial report, “Unstable Angina Global Clinical Trials Review, H2, 2016" provides an overview of Unstable Angina clinical trials scenario.September 9, 2016
Multiple Myeloma - China Drug Market Analysis to 2023 - Size, Competitive Landscape, Key Country overview and Forecasts
The Multiple Myeloma (MM) market is currently dominated by Velcade and Revlimid, and the market is set to undergo substantial growth between 2013 and 2023.September 9, 2016
Market artifice report on Chemotherapy Induced Neutropenia - Pipeline Review, H2 2016
The Chemotherapy Induced Neutropenia - Pipeline Review, H2 2016 report offers a comprehensive insight on the Chemotherapy Induced Neutropenia pipeline landscape.September 7, 2016
Market artifice report on Amyloidosis - Pipeline Review, H2 2016
The Amyloidosis - Pipeline Review, H2 2016 report offers a comprehensive insight on the Amyloidosis pipeline landscape.September 7, 2016
Study on potential market: High Affinity Nerve Growth Factor Receptor - Pipeline Review, H2 2016
Report offers a complete overview of the pharmaceutical research and development of the pipeline products that are developed by High Affinity Nerve Growth Factor ReceptorSeptember 6, 2016
Depth study on the Integrin Beta 1 - Pipeline Review, H2 2016
The Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H2 2016September 6, 2016